Logo image of PLUR

PLURI INC (PLUR) Stock Fundamental Analysis

USA - NASDAQ:PLUR - US72942G2030 - Common Stock

3.86 USD
-0.32 (-7.66%)
Last: 11/14/2025, 8:17:03 PM
Fundamental Rating

2

PLUR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. PLUR has a bad profitability rating. Also its financial health evaluation is rather negative. PLUR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PLUR has reported negative net income.
In the past year PLUR has reported a negative cash flow from operations.
PLUR had negative earnings in each of the past 5 years.
PLUR had a negative operating cash flow in each of the past 5 years.
PLUR Yearly Net Income VS EBIT VS OCF VS FCFPLUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of PLUR (-58.38%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -58.38%
ROE N/A
ROIC N/A
ROA(3y)-56.03%
ROA(5y)-56.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLUR Yearly ROA, ROE, ROICPLUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K -20K

1.3 Margins

Looking at the Gross Margin, with a value of 48.95%, PLUR is in the better half of the industry, outperforming 75.33% of the companies in the same industry.
In the last couple of years the Gross Margin of PLUR has declined.
PLUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.31%
PLUR Yearly Profit, Operating, Gross MarginsPLUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20K -40K -60K -80K -100K

0

2. Health

2.1 Basic Checks

PLUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PLUR has been increased compared to 1 year ago.
The number of shares outstanding for PLUR has been increased compared to 5 years ago.
PLUR has a worse debt/assets ratio than last year.
PLUR Yearly Shares OutstandingPLUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
PLUR Yearly Total Debt VS Total AssetsPLUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

PLUR has an Altman-Z score of -17.76. This is a bad value and indicates that PLUR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PLUR (-17.76) is worse than 82.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -17.76
ROIC/WACCN/A
WACC7.23%
PLUR Yearly LT Debt VS Equity VS FCFPLUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

PLUR has a Current Ratio of 0.68. This is a bad value and indicates that PLUR is not financially healthy enough and could expect problems in meeting its short term obligations.
PLUR has a worse Current ratio (0.68) than 91.15% of its industry peers.
PLUR has a Quick Ratio of 0.68. This is a bad value and indicates that PLUR is not financially healthy enough and could expect problems in meeting its short term obligations.
PLUR's Quick ratio of 0.68 is on the low side compared to the rest of the industry. PLUR is outperformed by 90.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
PLUR Yearly Current Assets VS Current LiabilitesPLUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.70% over the past year.
Looking at the last year, PLUR shows a very strong growth in Revenue. The Revenue has grown by 309.82%.
The Revenue has been growing by 63.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.23%
Revenue 1Y (TTM)309.82%
Revenue growth 3Y63.03%
Revenue growth 5YN/A
Sales Q2Q%314.58%

3.2 Future

PLUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.63% yearly.
Based on estimates for the next years, PLUR will show a very strong growth in Revenue. The Revenue will grow by 113.54% on average per year.
EPS Next Y87.65%
EPS Next 2Y37.16%
EPS Next 3Y19.26%
EPS Next 5Y12.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3Y90.39%
Revenue Next 5Y113.54%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PLUR Yearly Revenue VS EstimatesPLUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2018 2019 2020 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
PLUR Yearly EPS VS EstimatesPLUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30 -40

0

4. Valuation

4.1 Price/Earnings Ratio

PLUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PLUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PLUR Price Earnings VS Forward Price EarningsPLUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLUR Per share dataPLUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as PLUR's earnings are expected to grow with 19.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.16%
EPS Next 3Y19.26%

0

5. Dividend

5.1 Amount

PLUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PLURI INC

NASDAQ:PLUR (11/14/2025, 8:17:03 PM)

3.86

-0.32 (-7.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10
Earnings (Next)02-09 2026-02-09
Inst Owners19.6%
Inst Owner Change-0.22%
Ins Owners40.66%
Ins Owner Change4.37%
Market Cap31.50M
Revenue(TTM)1.34M
Net Income(TTM)-22.58M
Analysts82.86
Price Target12.24 (217.1%)
Short Float %0.32%
Short Ratio1.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-60.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.58
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.32
EYN/A
EPS(NY)-1.22
Fwd EYN/A
FCF(TTM)-2.43
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS0.16
BVpS-0.84
TBVpS-1.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -58.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.95%
FCFM N/A
ROA(3y)-56.03%
ROA(5y)-56.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.31%
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 512.03%
Cap/Sales 121.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z -17.76
F-Score3
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)237.36%
Cap/Depr(5y)153.18%
Cap/Sales(3y)103.83%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.23%
EPS Next Y87.65%
EPS Next 2Y37.16%
EPS Next 3Y19.26%
EPS Next 5Y12.63%
Revenue 1Y (TTM)309.82%
Revenue growth 3Y63.03%
Revenue growth 5YN/A
Sales Q2Q%314.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3Y90.39%
Revenue Next 5Y113.54%
EBIT growth 1Y-0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.05%
OCF growth 3YN/A
OCF growth 5YN/A

PLURI INC / PLUR FAQ

Can you provide the ChartMill fundamental rating for PLURI INC?

ChartMill assigns a fundamental rating of 2 / 10 to PLUR.


What is the valuation status of PLURI INC (PLUR) stock?

ChartMill assigns a valuation rating of 0 / 10 to PLURI INC (PLUR). This can be considered as Overvalued.


What is the profitability of PLUR stock?

PLURI INC (PLUR) has a profitability rating of 1 / 10.


How financially healthy is PLURI INC?

The financial health rating of PLURI INC (PLUR) is 0 / 10.